Vascular endothelial growth factor C-induced lymphangiogenesis decreases tumor interstitial fluid pressure and tumor

Translational Oncology

Volumn 6, Issue 4, 2013, Pages 398-404

  Hofmann, Matthias ^a   Pflanzer, Ralph ^a   Zöller, Nadja Nicole ^a   Bernd, August ^a   Kaufmann, Roland ^a   Thaci, Diamant ^a   Bereiter Hahn, Jürgen ^a   Hirohata, Satoshi ^b   Kippenberger, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; MOUSE; NONHUMAN; TISSUE PRESSURE; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84881048024     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.13274     Document Type: Article

References (40)

1. Wiig H, Tveit E, Hultborn R, Reed RK, and Weiss L (1982). Interstitial fluid pressure in DMBA-induced rat mammary tumours. Scan J Clin Lab Invest 42, 159-164.
2. Jain RK (1994). Barriers to drug delivery in solid tumors. Sci Am 271, 58-65.
3. Jain RK (1998). The next frontier of molecular medicine: delivery of therapeutics. Nat Med 4, 655-657.
4. Heldin CH, Rubin K, Pietras K, and Östman A (2004). High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer 4, 806-813.
5. Tufto I and Rofstad EK (1999). Interstitial fluid pressure and capillary diameter distribution in human melanoma xenografts. Microvasc Res 58, 205-214.
6. Carmeliet P and Jain RK (2000). Angiogenesis in cancer and other diseases. Nature 407, 249-257.
7. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, and Jain RK (2000). Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60, 4324-4327.
8. Jain RK (1987). Transport of molecules in the tumor interstitium: a review. Cancer Res 47, 3039-3051.
9. Jain RK (2001). Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release 74, 7-25.
10. Jain RK, Tong RT, and Munn LL (2007). Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res 67, 2729-2735.
11. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, and Jain RK (2004). Pathology: cancer cells compress intratumour vessels. Nature 427, 695.
12. Isaka N, Padera TP, Hagendoorn J, Fukumura D, and Jain RK (2004). Peritumor lymphatics induced by vascular endothelial growth factor-c exhibit abnormal function. Cancer Res 64, 4400-4404.
13. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, et al. (2002). Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296, 1883-1886.
14. Hofmann M, Guschel M, Bernd A, Bereiter-Hahn J, Kaufmann R, Tandi C, Wiig H, and Kippenberger S (2006). Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model. Neoplasia 8, 89-95.
15. Hofmann M, Schultz M, Bernd A, Bereiter-Hahn J, Kaufmann R, and Kippenberger S (2007). Long-term lowering of tumour interstitial fluid pressure reduces Ki-67 expression. J Biomech 40, 2324-2329.
16. Hofmann M, McCormack E, Mujic M, Rossberg M, Bernd A, Bereiter-Hahn J, Gjertsen BT, Wiig H, and Kippenberger S (2009). Increased plasma colloid osmotic pressure facilitates the uptake of therapeutic macromolecules in a xenograft tumor model. Neoplasia 11, 812-822.
17. Eriksson U and Alitalo K (1999). Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr Top Microbiol Immunol 237, 41-57.
18. Ferrara N (1999). Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237, 1-30.
19. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, and Alitalo K (1996). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.
20. Lymboussaki A, Olofsson B, Eriksson U, and Alitalo K (1999). Vascular endo-thelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Circ Res 85, 992-999.
21. Jeltsch MM, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, and Alitalo K (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425.
22. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K, and Wilting J (1997). VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188, 96-109.
23. Baumann M, Appold S, Zimmer J, Scharf M, Beuthien-Baumann B, Dubben HH, Enghardt W, Schreiber A, Eicheler W, and Petersen C (2001). Radio-biological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy. Acta Oncol 40(4), 519-528.
24. Obika M, Ogawa H, Takahashi K, Li J, Hatipoglu OF, Cilek MZ, Miyoshi T, Inagaki J, Ohtsuki T, Kusachi S, et al. (2012). Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis. Cancer Sci 103, 1889-1897.
25. Fadnes HO, Reed RK, and Aukland K (1997). Interstitial fluid pressure in rats measured with a modified wick technique. Microvasc Res 14, 27-36.
26. Pflanzer R, Shelke A, Bereiter-Hahn J, and Hofmann M (2012). Ultrasonic quantification of tumor interstitial fluid pressure through scanning acoustic microscopy. In Acoustical Imaging. Vol 31. A Nowicki, J Litniewski, and T Kujawska (Eds). Springer, Berlin, Germany. pp. 291-299.
27. Arimoto J, Ikura Y, Suekane T, Nakagawa M, Kitabayashi C, Iwasa Y, Sugioka K, Naruko T, Arakawa T, and Ueda M (2010). Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. J Gastroenterol 45, 317-325.
28. Swabb EA, Wei J, and Gullino PM (1974). Diffusion and convection in normal and neoplastic tissues. Cancer Res 34, 2814-2822.
29. Boucher Y and Jain RK (1992). Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52, 5110-5114.
30. Lee I, Boucher Y, Demhartner TJ, and Jain RK (1994). Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. Br J Cancer 69(3), 492-496.
31. Gutmann R, Leunig F, Feyh J, Goetz AE, Messmer K, Kastenbauer E, and Jain RK (1992). Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res 52, 1993-1995.
32. Nathanson SD and Nelson L (1994). Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma. Ann Surg Oncol 1, 333-338.
33. Stohrer M, Boucher Y, Stangassinger M, and Jain RK (2000). Oncotic pressure in solid tumors is elevated. Cancer Res 60, 4251-4255.
34. Nathan SS, Huvos AG, Casas-Ganem JE, Yang R, Linkov I, Sowers R, DiResta GR, Gorlick R, and Healey JH (2008). Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. J Orthop Res 26, 1520-1525.
35. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Reza Dana M, Wiegand SJ, and Streilein JW (2004). VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113, 1040-1050.
36. Halin C, Tobler NE, Vigl B, Brown LF, and Detmar M (2007). VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110, 3158-3167.
37. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, and Detmar M (2005). VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201, 1089-1099.
38. Stacker SA, Caesar C, Baldwin ME, Thornton GE, William RA, Prevo R, Jackson DG, Nishikawa SI, Kubo H, and Achen MG (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7, 186-191.
39. Shimizu Y, Shibata R, Shintani S, Ishii M, and Murohara T (2012). Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells. J Am Heart Assoc 1, e000877.
40. Mandiota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, et al. (2001). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20, 671-682.